Now showing items 1-10 of 88
Short synthesis of methylphenidate and its p-methoxy derivative
(Marcel Dekker IncNew YorkEUA, 2000)
Do Phenotypic Characteristics, Parental Psychopathology, Family Functioning, and Environmental Stressors Have a Role in the Response to Methylphenidate in Children With Attention-Deficit/Hyperactivity Disorder? A Naturalistic Study From a Developing Country
(LIPPINCOTT WILLIAMS & WILKINS, 2011)
Little is known about the effect of clinical characteristics, parental psychopathology, family functioning, and environmental stressors in the response to methylphenidate in children with attention-deficit/hyperactivity ...
Reproductive parameters of female Wistar rats treated with methylphenidate during development
(Elsevier B.V., 2016-12-01)
Methylphenidate (MPH), a psychoactive agent that acts mainly by blocking the uptake of dopamine, is the main drug used to treat Attention Deficit Hyperactivity Disorder in children and adolescents. During development, ...
Differential effects of methylphenidate and cocaine on GABA transmission in sensory thalamic nuclei
Methylphenidate (MPH) is widely used to treat children and adolescents diagnosed with attention deficit/hyperactivity disorder. Although MPH shares mechanistic similarities to cocaine, its effects on GABAergic transmission ...
Nitric oxide modulation of methylphenidate-induced disruption of prepulse inhibition in Swiss mice
(ELSEVIER SCIENCE BV, 2009)
Drugs that facilitate dopaminergic neurotransmission induce cognitive and attentional deficits which include inability to filter sensory input measured by prepulse inhibition (PPI) Methylphenidate, an amphetamine analog ...